A widely studied drug combination marketed for anti-aging purposes has demonstrated concerning neurotoxic effects in laboratory mice, according to recent research published in a leading neuroscience journal. The investigation revealed substantial brain tissue damage, particularly affecting myelin—the protective sheaths surrounding nerve fibers essential for proper neurological function.
Researchers observed cognitive impairments in treated mice that resembled “chemo brain,” a recognized side effect associated with cancer therapies. Most notably, the damaged brain cells exhibited cellular patterns strikingly similar to those found in multiple sclerosis patients, suggesting potential shared pathogenic mechanisms. These unexpected findings have prompted researchers to reconsider the safety profile of anti-aging compounds currently under investigation for human clinical application.
The results underscore the critical need for comprehensive preclinical safety evaluation before advancing longevity interventions toward human trials. Read the full article on GMJ Newsroom.
Was this article helpful?
